Andrew C. Picel, MD, is a board-certified interventional radiologist who specializes in diagnosing and treating disease with minimally invasive image guided procedures. These imaging techniques include X-ray, computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound.
Dr. Picel was one of the first physicians in the region to test a minimally invasive therapy to treat severe lower urinary tract symptoms related to benign prostate hyperplasia (BPH), called prostate artery embolization (PAE). This now FDA-approved treatment does not have the sexual side effects of transurethral resection of the prostate (TURP), the standard treatment for men who have not responded to medications and lifestyle modifications. He currently works closely with urologists to evaluate and treat patients with BPH.
Dr. Picel provides treatment for individuals with circulatory system diseases, such as peripheral arterial and venous disease. He performs numerous procedures for the treatment of venous insufficiency and varicose veins. These procedures commonly include endovenous ablation and sclerotherapy. Clinically, Dr. Picel also has a special interest in interventional oncology and performs TACE and TARE to treat patients with hepatocellular carcinoma (HCC). He also performs uterine fibroid embolization and occlusion balloon placement for invasive placenta.
An assistant professor in the Department of Radiology at Stanford University, Dr. Picel trains interventional radiology fellows and residents. His research interests focus on prostate artery embolization and pelvic embolization for invasive placenta.
Outside of work, Dr. Picel enjoys sailing, spending time with family, and traveling.